Nello Mainolfi, Kymera CEO (via YouTube)
Kymera, raising $173M+, becomes the 48th biotech IPO of the year as 2020 surpasses 2019
Yet another biotech will hit Nasdaq on Friday, and this one marks a milestone for 2020.
Cambridge, MA-based Kymera has priced its IPO, announcing a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
